ATOSSA THERAPEUTICS INC. - COMMON STOCK
1.5300
12-November-24 13:19:37
15 minutes delayed
Stocks
-0.0900
-5.56%
Today's range
1.5219 - 1.6200
ISIN
N/A
Source
NASDAQ
-
Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
13 May 2024 07:50:00 By Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces Support of New Breast Cancer Screening Guidelines
07 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
29 Apr 2024 07:30:00 By Nasdaq GlobeNewswire
-
Atossa to Participate in Noble Capital Markets Emerging Growth Healthcare Conference
11 Apr 2024 07:30:00 By Nasdaq GlobeNewswire
-
09 Apr 2024 10:59:00 By Nasdaq GlobeNewswire
-
NetDania - New 12 months High: ATOSSA THERAPEUTICS INC. - COMMON STOCK
05 Apr 2024 08:58:53 By NetDania Notify
-
NetDania - New 12 months High: ATOSSA THERAPEUTICS INC. - COMMON STOCK
04 Apr 2024 10:38:29 By NetDania Notify
-
Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update
01 Apr 2024 15:00:00 By Nasdaq GlobeNewswire
-
NetDania - New 12 months High: ATOSSA THERAPEUTICS INC. - COMMON STOCK
01 Apr 2024 11:27:21 By NetDania Notify
-
NetDania - New 12 months High: ATOSSA THERAPEUTICS INC. - COMMON STOCK
28 Mar 2024 09:08:00 By NetDania Notify
-
NetDania - New 12 months High: ATOSSA THERAPEUTICS INC. - COMMON STOCK
26 Mar 2024 08:45:03 By NetDania Notify
-
NetDania - New 12 months High: ATOSSA THERAPEUTICS INC. - COMMON STOCK
25 Mar 2024 09:40:51 By NetDania Notify
-
NetDania - New 12 months High: ATOSSA THERAPEUTICS INC. - COMMON STOCK
20 Mar 2024 08:45:01 By NetDania Notify
-
NetDania - New 12 months High: ATOSSA THERAPEUTICS INC. - COMMON STOCK
19 Mar 2024 09:49:14 By NetDania Notify
-
19 Mar 2024 07:30:00 By Nasdaq GlobeNewswire
-
Atossa Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirements
18 Mar 2024 07:30:00 By Nasdaq GlobeNewswire
-
12 Mar 2024 07:30:00 By Nasdaq GlobeNewswire
-
06 Mar 2024 07:30:00 By Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces First Patient Dosing of (Z)-Endoxifen in the Ongoing RECAST DCIS Study
22 Feb 2024 07:30:00 By Nasdaq GlobeNewswire